CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fabino Enterprises Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fabino Enterprises Ltd
B-Wing
Shubham Garden Complex, Murth
NEW DELHI, 110085  India Ticker: 543444543444
Business Summary
Fabino Enterprises Limited is an India-based pharmaceutical company. The Company specializes in sourcing active pharmaceutical ingredients (APIs) and offers a range of allopathic tablets and injectables. The Company's products include 21 No Tea, AMOXRAG-625, Astrid Syrup, Aur D3 Capsules, Aurceta AM, Aurcis-Forte, Aurifox OZ, Aurimor Gold, Aurimor plus, Aurirug 200, Aurirug O, Aurnim Plus, Aurstin 250, Aurstin 500, Aurzyme-Syrup, Ayush Kadha, Calogrip, Cefga 1gm, Cekal Forte, Ceporag O, Coptec Capsules, Coptec-syrup, Cough-Free, Dexrog Syrup, Dicarag Gel, Dicpa, Doref DS, Doref M, Dr-DSR, DStoren-Syrup, Ecstasy Tilla Oil, F Plexus A, Fab Cafe, Fablactin, Fabovit, and Fabpara, Fabvit C, Fabvita- Malt Protein, FABZYM CAPSULE, Giloy Power, Glucose, Guava Juice, Iorag-XT, Keepshine Hair Oil, Keepshine Shampoo, Lychee Juice, M-Sharp-Brain-tonic, Mango Juice, Massage Oil, Mefdic, Misar-40, and Misar-H.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2836 Biological products, except diagnostic substances

General Information
Number of Employees: 11 (As of 3/31/2024)
Outstanding Shares: 2,100,000 (As of 9/30/2024)
Stock Exchange: BOM


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 30, 2025